Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells.
about
Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodologyRegulatory B cells: an exciting target for future therapeutics in transplantationAberrant frequency of IL-10-producing B cells and its association with Treg/Th17 in adult primary immune thrombocytopenia patients.Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.L2pB1: a new player in autoimmunity.T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus.Multiple mechanisms of immune suppression by B lymphocytesThe BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cellsAdvances in human B cell phenotypic profiling.B Cells with Regulatory Function in Human DiseasesIL-10-producing regulatory B cells (B10 cells) in autoimmune disease.Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets.Cell type-specific regulation of IL-10 expression in inflammation and disease.What rheumatologists need to know about innate lymphocytes.Regulatory B Cells in Seropositive Myasthenia Gravis versus Healthy Controls.Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis.
P2860
Q25255941-B3EC3029-00A0-4C51-B61C-E6EEE49EEC77Q27015093-00DF1FBC-2EDA-49C9-8070-9DB4820BA9CAQ33416700-C125D4E0-ADF6-45BB-8E4B-1D4B0480D1EEQ34144779-FD51EA87-DDE2-4F91-868C-7AEC4CC7B8A4Q34927610-D619039F-FFDB-4D9C-9709-46D34FA76426Q35097391-DC7659E5-6ED3-4177-8466-7BFE7C1F8B39Q35747533-EF3A9803-BC35-4351-A8B1-A51D9961780EQ36165173-F6E38F41-EAF4-4010-9108-4BD804238685Q36307080-AB6A3FF3-61C6-4F35-A186-CFD6F58562C2Q36677543-EBC1C629-D0FF-45D5-B63B-78016109A25CQ36760499-7C232793-0F37-4083-A069-979DED41FC87Q37350948-E89A0EE5-7F0E-4432-850C-83F146FC6FBEQ37436035-AE3342AE-F55A-4798-BEB7-ECB0793DF515Q37678256-555EA986-762D-4E44-BB26-E76160A5C575Q38809547-D564AE66-BEB8-426C-B51C-C69C992EA5D6Q41980478-410CED73-3E02-4F32-9340-08A0350113C0Q45866879-4256AE25-CBEF-483C-B9CE-295B3373D7D6Q47980248-D2E8ABE9-6D34-4260-9345-3B38B9F8F551
P2860
Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Assessment of Be1 and Be2 cell ...... kin-10 producing CD5+ B cells.
@en
Assessment of Be1 and Be2 cell ...... kin-10 producing CD5+ B cells.
@nl
type
label
Assessment of Be1 and Be2 cell ...... kin-10 producing CD5+ B cells.
@en
Assessment of Be1 and Be2 cell ...... kin-10 producing CD5+ B cells.
@nl
prefLabel
Assessment of Be1 and Be2 cell ...... kin-10 producing CD5+ B cells.
@en
Assessment of Be1 and Be2 cell ...... kin-10 producing CD5+ B cells.
@nl
P2093
P2860
P1433
P1476
Assessment of Be1 and Be2 cell ...... ukin-10 producing CD5+ B cells
@en
P2093
M L Huggins
M R Amel Kashipaz
R J Powell
P2860
P304
P356
10.1191/0961203303LU338OA
P577
2003-01-01T00:00:00Z